Literature DB >> 15699157

A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions.

Lars Bellner1, Fredrik Thorén, Erik Nygren, Jan-Ake Liljeqvist, Anna Karlsson, Kristina Eriksson.   

Abstract

We have identified a synthetic peptide derived from the secreted portion of HSV type 2 glycoprotein G, denoted gG-2p20, which has proinflammatory properties in vitro. The gG-2p20 peptide, corresponding to aa 190-205 of glycoprotein G-2, was a chemoattractant for both monocytes and neutrophils in a dose-dependent fashion, and also induced the release of reactive oxygen from these cells. The receptor mediating the responses was identified as the formyl peptide receptor. The gG-2p20-induced activation of phagocytes had a profound impact on NK cell functions. The reactive oxygen species produced by gG-2p20-activated phagocytes both inhibited NK cell cytotoxicity and accelerated the apoptotic cell death in NK cell-enriched lymphocyte populations. Hence, we have for the first time been able to identify a potential function of the secreted portion of HSV-2 glycoprotein G. We propose that the proinflammatory gG-2p20 peptide identified could contribute to a reduced function and viability of NK cells during HSV-2 infection due to its ability to recruit and activate phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699157     DOI: 10.4049/jimmunol.174.4.2235

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Authors:  Gerlinde R Van de Walle; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

2.  Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.

Authors:  Manoj Thapa; William A Kuziel; Daniel J J Carr
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

4.  CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.

Authors:  Manoj Thapa; Daniel J J Carr
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

Review 5.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

6.  Virotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activity.

Authors:  X Fu; L Tao; A Rivera; H Xu; X Zhang
Journal:  Cancer Gene Ther       Date:  2011-08-26       Impact factor: 5.987

7.  Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.

Authors:  Abel Viejo-Borbolla; Nadia Martinez-Martín; Hendrik J Nel; Patricia Rueda; Rocío Martín; Soledad Blanco; Fernando Arenzana-Seisdedos; Marcus Thelen; Padraic G Fallon; Antonio Alcamí
Journal:  PLoS Pathog       Date:  2012-02-02       Impact factor: 6.823

Review 8.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

9.  Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages.

Authors:  Claudio Gemperle; Mattia Schmid; Magdalena Herova; Jacqueline Marti-Jaun; Sophia J A Wuest; Christa Loretz; Martin Hersberger
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Differential activation of polymorphisms of the formyl peptide receptor by formyl peptides.

Authors:  John S Mills
Journal:  Biochim Biophys Acta       Date:  2007-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.